⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Pulmonary embolism

5,969 total reports84.7% serious outcomes

Pulmonary embolism appears in 5,969 VAERS reports across all vaccines. Of these, 569 reports also mentioned death and 4,485 involved hospitalization. The severity rate (deaths + hospitalizations as a percentage of reports) is 84.7%. The top vaccines associated with this symptom are COVID-19, COVID-19 (Bivalent), HPV (Gardasil). Remember: VAERS reports show temporal association, not causation.

5,969

Total Reports

569

Deaths

4,485

Hospitalizations

84.7

Severity Rate

% serious outcomes

About Pulmonary embolism Reports

Pulmonary embolism has been reported 5,969 times in VAERS from 1990 to 2026.

Of these reports, 569 were associated with death (9.53%) and 4,485 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Pulmonary embolism is 84.7%.

Understanding Pulmonary embolism in VAERS

•Temporal association only: These reports show Pulmonary embolism occurred after vaccination, not necessarily because of vaccination.

•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.

•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.

•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Pulmonary embolism. This may reflect usage patterns, not causation.

Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.

Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.